This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.62% per year. These returns cover a period from January 1, 1988 through June 2, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
electric-vehicles: Archive
Will Carvana Extend Its Streak of Record Retail Sales in Q2?
by Lavina Shahu
CVNA's record Q1 sales and rising momentum set the stage for a possible fifth straight quarter of growth.
GPINegative Net Change LADNegative Net Change CVNAPositive Net Change
auto-tires-trucks electric-vehicles
Ford Pauses Mustang Mach-E Sales Due to Door Lock Issue
by Zacks Equity Research
F halts Mustang Mach-E sales globally after door defect raises safety concerns; software fix expected in Q3 2025.
FNegative Net Change STRTNegative Net Change MGDDYNegative Net Change CARGNegative Net Change
auto-tires-trucks electric-vehicles
After Golden Cross, Agenus (AGEN)'s Technical Outlook is Bright
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
AGENNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Sportsman's Warehouse (SPWH)'s Technical Outlook is Bright After Key Golden Cross
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
SPWHNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Will Higher Production Volumes of R2 Boost Rivian's Gross Profit?
by Lavina Shahu
RIVN hits record gross profit and eyes margin gains from higher R2 output as it gears up for 2026 launch.
TSLANegative Net Change LCIDNegative Net Change RIVNNegative Net Change
auto-tires-trucks electric-vehicles
Will New Launches Drive NIO's Gross Margin Expansion in 2025?
by Lavina Shahu
NIO's rising vehicle margins, new model rollouts, and cost efficiencies signal improvement in overall gross margins.
NIONegative Net Change LIPositive Net Change XPEVNegative Net Change
auto-tires-trucks electric-vehicles
After Golden Cross, Diversified Healthcare (DHC)'s Technical Outlook is Bright
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
DHCNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Box (BOX) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
BOXNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Nissan Considers Stake Reduction in Renault to Fund New Investments
by Zacks Equity Research
NSANY plans to trim its stakes in Renault to fund new vehicle development as part of a broader restructuring push.
NSANYNegative Net Change RNLSYNegative Net Change MGDDYNegative Net Change CARGNegative Net Change
auto-tires-trucks electric-vehicles
TSLA's Legacy or RIVN's Promise: Which EV Story Holds Up Better Now?
by Rimmi Singhi
Tesla's slowing growth and Rivian's high cash burn reveal the EV sector's growing pains, with each stock facing tough tradeoffs.
TSLANegative Net Change RIVNNegative Net Change
electric-vehicles
Zacks Investment Ideas feature highlights: Tesla, Li Auto, Nio, BYD and Alphabet
by Zacks Equity Research
Zacks spotlights Tesla, Alphabet, and top Chinese EV makers as the Robotaxi race heats up with tech and scale advantages.
TSLANegative Net Change GOOGLNegative Net Change NIONegative Net Change BYDDYNegative Net Change LIPositive Net Change
auto-tires-trucks computers electric-vehicles
Should You Buy Credo Technology Group Holding Ltd. (CRDO) After Golden Cross?
by Zacks Equity Research
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
CRDONegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Amarin (AMRN) Now Trades Above Golden Cross: Time to Buy?
by Zacks Equity Research
Should investors be excited or worried when a stock's 50 -day simple moving average crosses above the 200-day simple moving average?
AMRNPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Should You Buy Alpha Cognition Inc. (ACOG) After Golden Cross?
by Zacks Equity Research
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
ACOGPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Do Tesla's Refreshed Model X & S Offer Value Over Competitors?
by Zacks Equity Research
TSLA unveils updated Model S and X with modest upgrades and $5,000 price hikes amid rising competition.
TSLANegative Net Change LCIDNegative Net Change RIVNNegative Net Change
auto-tires-trucks electric-vehicles
Under $5 and Down 20% YTD, Is NIO Stock a Bargain Buy Now?
by Rimmi Singhi
NIO stock trades below $5 despite delivery growth, new models & tech gains. But with weak margins & fierce EV price wars, is it worth buying now?
NIONegative Net Change LIPositive Net Change XPEVNegative Net Change
electric-vehicles
Time to Ride Tesla ETFs on Recent Stock Rebound & Robotaxi Launch?
by Sanghamitra Saha
Tesla rebounded 14% last week after Musk???s apology and robotaxi buzz, lifting ETFs like TESL and TSLW sharply higher.
TSLANegative Net Change XLYNegative Net Change NITENegative Net Change TSLWNegative Net Change TESLNegative Net Change
electric-vehicles etfs
BYD Introduces Most Affordable EV Model in the United Kingdom
by Zacks Equity Research
BYDDY launches its most affordable EV model, Dolphin Surf, priced from around $25,000, in the United Kingdom.
STRTNegative Net Change MGDDYNegative Net Change CARGNegative Net Change BYDDYNegative Net Change
auto-tires-trucks electric-vehicles
Is Carvana's Vending Machine Model Enhancing Efficiency?
by Zacks Equity Research
CVNA's car vending machines are boosting market reach and reducing variable operating costs per vehicle sold.
GPINegative Net Change LADNegative Net Change CVNAPositive Net Change
auto-tires-trucks electric-vehicles
Does Rivian's AI-Driven RAP Provide It a Competitive Edge?
by Zacks Equity Research
RIVN's AI-powered Rivian Autonomy Platform, standard on R1 models, boosts its edge in the EV driver-assist race.
TMNegative Net Change TSLANegative Net Change GOOGLNegative Net Change RIVNNegative Net Change
auto-tires-trucks electric-vehicles
Five Below (FIVE) Now Trades Above Golden Cross: Time to Buy?
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
FIVENegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
General Motors to Make an Investment of $4B in Three U.S. Plants
by Zacks Equity Research
GM to invest $4 billion in U.S. plants to relocate Blazer production from Mexico and supplement Equinox output amid tariff-driven production rethink.
GMNegative Net Change STRTNegative Net Change MGDDYNegative Net Change CARGNegative Net Change
auto-tires-trucks electric-vehicles
Celestica Margin Pressure Likely to Continue on Macro Woes
by Supriyo Bose
CLS faces ongoing margin pressure despite AI-driven growth and U.S. policy relief for key data center hardware.
JBLNegative Net Change CLSNegative Net Change SANMNegative Net Change
artificial-intelligence electric-vehicles iot tech-stocks
Should You Buy Allegro MicroSystems, Inc. (ALGM) After Golden Cross?
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
ALGMNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
The Zacks Analyst Blog Highlights Tesla, Alphabet and Baidu
by Zacks Equity Research
TSLA's long-awaited robotaxi launch is set for June 22, but rivals like Waymo and Baidu already have a big head start.
BIDUPositive Net Change TSLANegative Net Change GOOGLNegative Net Change
auto-tires-trucks computers electric-vehicles